This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 28 PubMed articles · model: gemma4:31b
Summary
Spirulina platensis is a blue-green microalga used as a nutritional supplement with reported antioxidant, anti-inflammatory, and neuroprotective properties [PMID:36453480, PMID:33612469].
Background
Spirulina platensis (also known as Arthrospira platensis) is a photosynthetic, spiral-shaped cyanobacterium from the class Cyanophyceae found in fresh water [PMID:30000909, PMID:36453480, PMID:38110108].
Traditional uses
It has been applied for over 400 years and is traditionally used as a food supplement and medical ingredient [PMID:36453480, PMID:36632963].
Active compounds
Key components include proteins, B vitamins (B1, B2), vitamin E, chlorophyll, beta-carotene, iron, phycocyanin, polyphenols, carotenoids, and gamma-linolenic fatty acid [PMID:30000909, PMID:36798131, PMID:15049159]. It also contains polysaccharides (SPPs) and very-long-chain polyunsaturated fatty acids (VLCPUFAs) such as precursors to EPA and DHA [PMID:36632963, PMID:35023103].
Mechanism of action
Spirulina exhibits antioxidant activity by increasing transcript levels of NRF-2 and Keap1 while decreasing gene expressions of Akt and eNOS [PMID:36432871]. Its polysaccharides may regulate gut microbiota properties [PMID:36632963]. Additionally, its polyphenolic contents may inhibit bacterial motility, invasion, biofilm formation, and quorum sensing by weakening bacterial cell walls [PMID:36798131].
Clinical evidence
Evidence BRebound dyspeptic symptoms after PPI discontinuation
A phase 2 placebo-controlled trial assessed whether Spirulina platensis can minimize rebound symptoms through anti-inflammatory and analgesic properties [PMID:38401078]
Evidence CGeneral Pharmacological Effects
Review of literature attributes antioxidative, anti-inflammatory, anti-neoplastic, hypolipidemic, antiviral, immunomodulatory, antimicrobial, anti-atherogenic, anti-diabetic, and radio-protective functions to Spirulina [PMID:36453480]
Evidence DOxidative Stress (HepG2 cells)
Spirulina platensis demonstrated a protective role against antiretroviral drug-induced oxidative stress in human liver cells [PMID:36432871]
Evidence DSchizophrenia (Animal Model)
Spirulina platensis showed neuroprotective effects in ameliorating psychosis-like symptoms in a dizocilpine-induced rat model [PMID:33612469]
Safety & adverse effects
Generally well tolerated when grown under controlled conditions [PMID:30000909]. Minor adverse effects include diarrhea, bloating, upset stomach, flatulence, edema, headache, muscle pain, facial flushing, and sweating [PMID:30000909]. Products grown in uncontrolled conditions may contain heavy metals or be contaminated with Microcystis aeruginosa, which produces hepatotoxins called microcystins [PMID:30000909].
Pregnancy & lactation
No specific lactation-related uses are known; no data exist on safety, efficacy, or excretion into breastmilk for nursing mothers or infants, although one case of green breastmilk discoloration was reported [PMID:30000909].
Evidence summary
Evidence ranges from high-level clinical trials for specific gastrointestinal symptoms to preclinical animal and in vitro studies supporting broad antioxidant and neuroprotective claims. Much of the available data is based on reviews or animal models.
PubMed sources
1.PMID: 30000909 (2006) — Food and drug industry applications of microalgae Spirulina platensis: A review. · Journal of basic microbiology
2.PMID: 36453480 (2023) — An Overview of Pharmacological and Clinical Aspects of Spirulina. · Current drug discovery technologies
3.PMID: 36632963 (2023) — Polysaccharides from Spirulina platensis: Extraction methods, structural features and bioactivities diversity. · International journal of biological macromolecules
4.PMID: 33612469 (2020) — Spirulina platensis (Blue-green algae): A miracle from sea combats the oxidative stress and improves behavioral deficits in an animal model of Schizophrenia. · Pakistan journal of pharmaceutical sciences
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
— Potential of Spirulina platensis as a feed supplement for poultry to enhance growth performance and immune modulation.
· Frontiers in immunology
6.PMID: 36432871 (2022) — Spirulina platensis Ameliorates Oxidative Stress Associated with Antiretroviral Drugs in HepG2 Cells. · Plants (Basel, Switzerland)
7.PMID: 35023103 (2021) — Phospholipid Fatty Acid Profile of Spirulina platensis. · Advances in experimental medicine and biology
8.PMID: 15049159 (2004) — [Microalgae Spirulina in human nutrition]. · Voprosy pitaniia
9.PMID: 38110108 (2024) — Purification of thioredoxin reductase from Spirulina platensis by affinity chromatography and investigation of kinetic properties. · Protein expression and purification
10.PMID: 38401078 (2024) — Spirulina Platensis Attenuates Rebound Dyspeptic Symptoms After Proton Pump Inhibitors' Discontinuation: Phase 2 Placebo-controlled Trial. · Alternative therapies in health and medicine